Lipoarabinomannans: From structure to biosynthesis

Biochimie

Volumn 85, Issue 1-2, 2003, Pages 153-166

  Nigou, Jérôme ^a   Gilleron, Martine ^a   Puzo, Germain ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Lipoglycan; Mycobacterium; Rhodococcus; Tuberculosis

Indexed keywords

INOSITOL PHOSPHATE; LIPOARABINOMANNAN; MANNAN; MANNOSE;

ACTINOBACTERIA; ANTIINFLAMMATORY ACTIVITY; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL VIRULENCE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CORYNEBACTERIUM; IMMUNE RESPONSE; MOLECULAR DYNAMICS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN MOTIF; REVIEW; RHODOCOCCUS; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); CORYNEBACTERINEAE; CORYNEBACTERIUM; GORDONIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; RHODOCOCCUS;

EID: 0038175124     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(03)00048-8     Document Type: Review

References (111)

1. World Health Organization, Tuberculosis, Fact Sheet No 104, World Health Organization, Geneva, Available from http://www.who.int/mediacentre/factsheets/who104/en/.
2. D.G. Russell, Mycobacterium tuberculosis: Here today, and here tomorrow, Nat. Rev. Mol. Cell. Biol. 2 (2001) 569-577.
3. S.H. Kaufmann, How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1 (2001) 20-30.
4. R. Doffinger, F. Altare, J.L. Casanova, Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection, Microbes Infect. 2 (2000) 1553-1557.
5. T.H. Ottenhoff, F.A. Verreck, E.G. Lichtenauer-Kaligis, M.A. Hoeve, O. Sanal, J.T. Van Dissel, Genetics, cytokines and human infectious disease: Lessons from weakly pathogenic mycobacteria and salmonellae, Nat. Genet. 32 (2002) 97-105.
6. G.J. Nau, J.F. Richmond, A. Schlesinger, E.G. Jennings, E.S. Lander, R.A. Young, Human macrophage activation programs induced by bacterial pathogens, Proc. Natl. Acad. Sci. USA 99 (2002) 1503-1508.
7. P.J. Brennan, H. Nikaido, The envelope of mycobacteria, Annu. Rev. Biochem. 64 (1995) 29-63.
8. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B.G. Barrell, et al., Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature 393 (1998) 537-544.
9. D. Chatterjee, The mycobacterial cell wall: Structure, biosynthesis and sites of drug action, Curr. Opin. Chem. Biol. 1 (1997) 579-588.
10. D. Chatterjee, K.H. Khoo, Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects, Glycobiology 8 (1998) 113-120.
11. A. Vercellone, J. Nigou, G. Puzo, Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis, Front. Biosci. 3 (1998) e149-e163.
12. G.R. Strohmeier, M.J. Fenton, Roles of lipoarabinomannan in the pathogenesis of tuberculosis, Microbes Infect. 1 (1999) 709-717.
13. M. Gilleron, M. Rivière, G. Puzo, Roles of glycans in bacterial infections: Interaction host-mycobacteria, in: M. Aubery (Ed.), Glycans in Cell Interaction and Recognition, Therapeutic Aspects, Harwood Academic Press, Amsterdam, 2001, pp. 113-140.
14. J. Nigou, M. Gilleron, M. Rojas, L.F. Garcia, M. Thurnher, G. Puzo, Mycobacterial lipoarabinomannans: Modulators of dendritic cell function and the apoptotic response, Microbes Infect. 4 (2002) 945-953.
15. K.L. Knutson, Z. Hmama, P. Herrera-Velit, R. Rochford, N.E. Reiner, Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. Role of the Src homology 2 containing tyrosine phosphatase 1, J. Biol. Chem. 273 (1998) 645-652.
16. J. Nigou, C. Zelle-Rieser, M. Gilleron, M. Thurnher, G. Puzo, Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor, J. Immunol. 166 (2001) 7477-7485.
17. Y. Guerardel, E. Maes, E. Elass, Y. Leroy, P. Timmerman, G.S. Besra, C. Locht, G. Strecker, L. Kremer, Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains, J. Biol. Chem. 277 (2002) 30635-30648.
18. L.S. Schlesinger, S.R. Hull, T.M. Kaufman, Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages, J. Immunol. 152 (1994) 4070-4079.
19. A. Venisse, J.J. Fournie, G. Puzo, Mannosylated lipoarabinomannan interacts with phagocytes, Eur. J. Biochem. 231 (1995) 440-447.
20. L.S. Schlesinger, T.M. Kaufman, S. Iyer, S.R. Hull, L.K. Marchiando, Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages, J. Immunol. 157 (1996) 4568-4575.
21. S. Sidobre, J. Nigou, G. Puzo, M. Riviere, Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition, J. Biol. Chem. 275 (2000) 2415-2422.
22. J.S. Ferguson, D.R. Voelker, F.X. McCormack, L.S. Schlesinger, Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages 1, J. Immunol. 163 (1999) 312-321.
23. V.Y. Polotsky, J.T. Belisle, K. Mikusova, R.A. Ezekowitz, K.A. Joiner, Interaction of human mannose-binding protein with Mycobacterium avium, J. Infect. Dis. 175 (1997) 1159-1168.
24. H.C. Hoppe, B.J. De Wet, C. Cywes, M. Daffe, M.R. Ehlers, Identification of phosphatidylinositol mannoside as a mycobacterial adhesion mediating both direct and opsonic binding to nonphagocytic mammalian cells, Infect. Immun. 65 (1997) 3896-3905.
25. L. Tailleux, O. Schwartz, J.L. Herrmann, E. Pivert, M. Jackson, A. Amara, L. Legres, D. Dreher, L.P. Nicod, J.C. Gluckman, P.H. Lagrange, B. Gicquel, O. Neyrolles, DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells, J. Exp. Med. 197 (2003) 121-127.
26. T.B. Geijtenbeek, S.J. Van Vliet, E.A. Koppel, M. Sanchez-Hernandez, C.M. Vandenbroucke-Grauls B. Appelmelk, Y. Van Kooyk, Mycobacteria target DC-SIGN to suppress dendritic cell function, J. Exp. Med. 197 (2003) 7-17.
27. N. Maeda, J. Nigou, J.L. Herrmann, M. Jackson, A. Amara, P.H. Lagrange, G. Puzo, B. Gicquel, O. Neyrolles, The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan, J. Biol. Chem. 278 (2002) 5516.
28. S. Ilangumaran, S. Arni, M. Poincelet, J.M. Theler, P.J. Brennan, D. Nasir Ud, D.C. Hoessli, Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes, J. Immunol. 155 (1995) 1334-1342.
29. J. Pugin, I.D. Heumann, A. Tomasz, V.V. Kravchenko, Y. Akamatsu, M. Nishijima, M.P. Glauser, P.S. Tobias, R.J. Ulevitch, CD14 is a pattern recognition receptor, Immunity 1 (1994) 509-516.
30. G. Kaplan, R.R. Gandhi, D.E. Weinstein, W.R. Levis, M.E. Patarroyo, P.J. Brennan, Z.A. Cohn, Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro, J. Immunol. 138 (1987) 3028-3034.
31. C. Moreno, A. Mehlert, J. Lamb, The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation, Clin. Exp. Immunol. 74 (1988) 206-210.
32. A. Molloy, G. Gaudernack, W.R. Lewis, Z.A. Cohn, G. Kaplan, Suppression of T-cell proliferation by Mycobacterium leprae and its products: The role of lipopolysaccharide, Proc. Natl. Acad. Sci. USA 87 (1990) 973-977.
33. J. Chan, X.D. Fan, S. W. Hunter, P.J. Brennan, B.R. Bloom, Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages, Infect. Immun. 59 (1991) 1755-1761.
34. L.D. Sibley, S.W. Hunter, P.J. Brennan, J.L. Krahenbuhl, Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages, Infect. Immun. 56 (1988) 1232-1236.
35. L.D. Sibley, L.B. Adams, J.L. Krahenbuhl, Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan, Clin. Exp. Immunol. 80 (1990) 141-148.
36. M. Rojas, L.F. Barrera, G. Puzo, L.F. Garcia, Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: Role of nitric oxide and mycobacterial products, J. Immunol. 159 (1997) 1352-1361.
37. 2+-dependent cell signaling, J. Infect. Dis. 182 (2000) 240-251.
38. D. Maiti, A. Bhattacharyya, J. Basu, Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathway, J. Biol. Chem. 276 (2001) 329-333.
39. E.D. Chan, K.R. Morris, J.T. Belisle, P. Hill, L.K. Remigio, P.J. Brennan, D.W. Riches, Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways, Infect. Immun. 69 (2001) 2001-2010.
40. C.A. Rivera-Marrero, W. Schuyler, S. Roser, J.D. Ritzenthaler, S.A. Newburn, J. Roman, M. tuberculosis induction of matrix metalloproteinase-9: The role of mannose and receptor-mediated mechanisms, Am. J. Physiol. Lung Cell. Mol. Physiol. 282 (2002) L546-L555.
41. T.K. Means, S. Wang, E. Lien, A. Yoshimura, D.T. Golenbock, M.J. Fenton, Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis, J. Immunol. 163 (1999) 3920-3927.
42. L.B. Adams, Y. Fukotomi, J.L. Krahenbuhl, Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence, Infect. Immun. 61 (1993) 4173-4181.
43. L.S. Anthony, D. Chatterjee, P.J. Brennan, F.E. Nano, Lipoarabinomannan from Mycobacterium tuberculosis modulates the generation of reactive nitrogen intermediates by gamma interferon-activated macrophages, FEMS Immunol. Med. Microbiol. 8 (1994) 299-305.
44. G.B. Schuller-Levis, W.R. Levis, M. Ammazzalorso, A. Nosrati, E. Park, Mycobacterial lipoarabinomannan induces nitric oxide and tumor necrosis factor alpha production in a macrophage cell line: Down regulation by taurine chloramine, Infect. Immun. 62 (1994) 4671-4674.
45. V. Vouret-Craviari, C. Matteucci, G. Peri, G. Poli, M. Introna, A. Mantovani, Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan, Infect. Immun. 65 (1997) 1345-1350.
46. S. Ghosh, S. Pal, S. Das, S.K. Dasgupta, S. Majumdar, Lipoarabinomannan induced cytotoxic effects in human mononuclear cells, FEMS Immunol. Med. Microbiol. 21 (1998) 181-188.
47. P.F. Barnes, D. Chatterjee, J.S. Abrams, S. Lu, E. Wang, M. Yamamura, P.J. Brennan, R.L. Modlin, Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure, J. Immunol. 149 (1992) 541-547.
48. D. Chatterjee, A.D. Roberts, K. Lowell, P.J. Brennan, I.M. Orme, Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor, Infect. Immun. 60 (1992) 1249-1253.
49. Y. Zhang, M. Doerfler, T.C. Lee, B. Guillemin, W.N. Rom, Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components, J. Clin. Invest. 91 (1993) 2076-2083.
50. M.C. Brown, S.M. Taffet, Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages, Infect. Immun. 63 (1995) 1960-1968.
51. K.E. Dahl, H. Shiratsuchi, B.D. Hamilton, J.J. Ellner, Z. Toossi, Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis, Infect. Immun. 64 (1996) 399-405.
52. M. Gilleron, N. Himoudi, O. Adam, P. Constant, A. Venisse, M. Riviere, G. Puzo, Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans. Structure and localization of alkali-labile and alkali-stable phosphoinositides, J. Biol. Chem. 272 (1997) 117-124.
53. A. Yoshida, Y. Koide, Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages, Infect. Immun. 65 (1997) 1953-1955.
54. Y. Zhang, W.N. Rom, Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs, Mol. Cell. Biol. 13 (1993) 3831-3837.
55. Y. Zhang, M. Broser, H. Cohen, M. Bodkin, K. Law, J. Reibman, W.N. Rom, Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components, J. Clin. Invest. 95 (1995) 586-592.
56. D.D. Riedel, S.H. Kaufmann, Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan, Infect. Immun. 65 (1997) 4620-2623.
57. V. Vouret-Craviari, S. Cenzuales, G. Poli, A. Mantovani, Expression of monocyte chemotactic PROTEIN-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan, Cytokine 9 (1997) 992-998.
58. T.I. Roach, C.H. Barton, D. Chatterjee, J.M. Blackwell, Macrophage activation: Lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha, J. Immunol. 150 (1993) 1886-1896.
59. T.I. Roach, D. Chatterjee, J.M. Blackwell, Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: Regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp), Infect. Immun. 62 (1994) 1176-1184.
60. P.A. Sieling, D. Chatterjee, S.A. Porcelli, T.I. Prigozy, R.J. Mazzaccaro, T. Soriano, B.R. Bloom, M.B. Brenner, M. Kronenberg, P.J. Brennan, et al., CD1-restricted T cell recognition of microbial lipoglycan antigens, Science 269 (1995) 227-230.
61. E.M. Beckman, A. Melian, S.M. Behar, P.A. Sieling, D. Chatterjee, S.T. Furlong, R. Matsumoto, J.P. Rosat, R.L. Modlin, S.A. Porcelli, CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J. Immunol. 157 (1996) 2795-2803.
62. A. Venisse, J.M. Berjeaud, P. Chaurand, M. Gilleron, G. Puzo, Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry, J. Biol. Chem. 268 (1993) 12401-12411.
63. A. Treumann, F. Xidong, L. McDonnell, P.J. Derrick, A.E. Ashcroft, D. Chatterjee, S.W. Homans, 5-Methylthiopentose: A new substituent on lipoarabinomannan in Mycobacterium tuberculosis, J. Mol. Biol. 316 (2002) 89-100.
64. P. Ludwiczak, M. Gilleron, Y. Bordat, C. Martin, B. Gicquel, G. Puzo, Mycobacterium tuberculosis phoP mutant: Lipoarabinomannan molecular structure, Microbiology 148 (2002) 3029-3037.
65. C. Delmas, M. Gilleron, T. Brando, A. Vercellone, M. Gheorghui, M. Riviere, G. Puzo, Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: Characterization and localization of succinates, Glycobiology 7 (1997) 811-817.
66. J. Nigou, A. Vercellone, G. Puzo, New structural insights into the molecular deciphering of mycobacterial lipoglycan binding to C-type lectins: Lipoarabinomannan glycoform characterization and quantification by capillary electrophoresis at the subnanomole level, J. Mol. Biol. 299 (2000) 1353-1362.
67. K.H. Khoo, E. Douglas, P. Azadi, J.M. Inamine, G.S. Besra, K. Mikusova, P.J. Brennan, D. Chatterjee, Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol, J. Biol. Chem. 271 (1996) 28682-28690.
68. D. Chatterjee, C.M. Bozic, M. McNeil, P.J. Brennan, Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis, J. Biol. Chem. 266 (1991) 9652-9660.
69. D. Chatterjee, K.H. Khoo, M.R. McNeil, A. Dell, H.R. Morris, P.J. Brennan, Structural definition of the non-reducing termini of mannose-capped LAM from Mycobacterium tuberculosis through selective enzymatic degradation and fast atom bombardment-mass spectrometry, Glycobiology 3 (1993) 497-506.
70. K.H. Khoo, A. Dell, H.R. Morris, P.J. Brennan, D. Chatterjee, Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: Definition of a common anchor for lipomannan and lipoarabinomannan, Glycobiology 5 (1995) 117-127.
71. J. Nigou, M. Gilleron, G. Puzo, Lipoarabinomannans: Characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy, Biochem. J. 337 (1999) 453-460.
72. M. Gilleron, J. Nigou, B. Cahuzac, G. Puzo, Structural study of the lipomannans from Mycobacterium bovis BCG: Characterisation of multiacylated forms of the phosphatidyl-myo-inositol anchor, J. Mol. Biol. 285 (1999) 2147-2160.
73. M. Gilleron, L. Bala, T. Brando, A. Vercellone, G. Puzo, Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans. Characterization of the acyl- and glyco-forms, J. Biol. Chem. 275 (2000) 677-684.
74. M.A. Behr, M.A. Wilson, W.P. Gill, H. Salamon, G.K. Schoolnik, S. Rane, P.M. Small, Comparative genomics of BCG vaccines by whole-genome DNA microarray, Science 284 (1999) 1520-1523.
75. D. Chatterjee, K. Lowell, B. Rivoire, M.R. McNeil, P.J. Brennan, Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains, J. Biol. Chem. 267 (1992) 6234-6239.
76. K.H. Khoo, A. Dell, H.R. Morris, P.J. Brennan, D. Chatterjee, Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium, J. Biol. Chem. 270 (1995) 12380-12389.
77. K.H. Khoo, J.B. Tang, D. Chatterjee, Variation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex, J. Biol. Chem. 276 (2001) 3863-3871.
78. P. Ludwiczak, Adaptation des mycobactéries à leur environnement: Nouvelles approches par spectrométrie de masse, Thèse de doctorat de l'Université Paul Sabatier, Toulouse, 2002.
79. J. Désiré, J. Prandi, Synthesis of methyl beta-D-arabinofuranoside 5-[1D (and L)-myo-inositol 1-phosphate], the capping motif of the lipoarabinomannan of Mycobacterium smegmatis, Carbohydr. Res. 317 (1999) 110-118.
80. N.J. Garton, M. Gilleron, T. Brando, H.H. Dan, S. Giguere, G. Puzo, J.F. Prescott, I.C. Sutcliffe, A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production, J. Biol. Chem. 277 (2002) 31722-31733.
81. I.C. Sutcliffe, Identification of a lipoarabinomannan-like lipoglycan in Corynebacterium matruchotii, Arch. Oral. Biol. 40 (1995) 1119-1124.
82. I.C. Sutcliffe, Characterisation of a lipomannan lipoglycan from the mycolic acid containing actinomycete Dietzia maris, Antonie Van Leeuwenhoek 78 (2000) 195-201.
83. C. Flaherty, I.C. Sutcliffe, Identification of a lipoarabinomannan-like lipoglycan in Gordonia rubropertincta, Syst. Appl. Microbiol. 22 (1999) 530-533.
84. C. Flaherty, D.E. Minnikin, I.C. Sutcliffe, A chemotaxonomic study of the lipoglycans of Rhodococcus rhodnii N445 (NCIMB 11279), Zentralbl. Bakteriol. 285 (1996) 11-19.
85. M. Gilleron, C. Ronet, M. Mempel, B. Monsarrat, G. Gachelin, G. Puzo, Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells, J. Biol. Chem. 276 (2001) 34896-34904.
86. A.E. Belanger, J.M. Inamine, Genetics of cell wall biosynthesis, in: G.F. Hatfull, W.R. Jacobs (Eds.), Molecular Genetics of Mycobacteria, ASM Press, Washington, DC, 2000, pp. 191-202.
87. M. Jackson, D.C. Crick, P.J. Brennan, Phosphatidylinositol is an essential phospholipid of mycobacteria, J. Biol. Chem. 275 (2000) 30092-30099.
88. M. Salman, J.T.G.S. Lonsdale Besra, P.J. Brennan, Phosphatidylinositol synthesis in mycobacteria, Biochim. Biophys. Acta 1436 (1999) 437-450.
89. J. Nigou, G.S. Besra, Cytidine diphosphate-diacylglycerol synthesis in Mycobacterium smegmatis, Biochem. J. 367 (2002) 157-162.
90. N. Bachhawat, S.C. Mande, Identification of the INO1 gene of Mycobacterium tuberculosis H37Rv reveals a novel class of inositol-1-phosphate synthase enzyme, J. Mol. Biol. 291 (1999) 531-536.
91. R.A. Norman, M.S. McAlister, J. Murray-Rust, F. Movahedzadeh, N.G. Stoker, N.Q. McDonald, Crystal structure of inositol 1-phosphate synthase from Mycobacterium tuberculosis, a key enzyme in phosphatidylinositol synthesis (Camb), Structure 10 (2002) 393-402.
92. J. Nigou, G.S. Besra, Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis, Biochem. J. 361 (2002) 385-390.
93. J. Nigou, L.G. Dover, G.S. Besra, Purification and biochemical characterization of Mycobacterium tuberculosis SuhB, an inositol monophosphatase involved in inositol biosynthesis, Biochemistry 41 (2002) 4392-4398.
94. T. Parish, J. Liu, H. Nikaido, N.G. Stoker, A Mycobacterium smegmatis mutant with a defective inositol monophosphate phosphatase gene homolog has altered cell envelope permeability, J. Bacteriol. 179 (1997) 7827-7833.
95. P. Brennan, C.E. Ballou, Biosynthesis of mannophosphoinositides by Mycobacterium phlei. The family of dimannophosphoinositides, J. Biol. Chem. 242 (1967) 3046-3056.
96. C.E. Ballou, Biosynthesis of mannophosphoinositides in Mycobacterium phlei, Methods Enzymol. 28 (1972) 493-500.
97. J. Nigou, Structure et propriétés immunomodulatrices de lipoglycannes atypiques: Les lipoarabinomannanes mycobactériens, Thèse de doctorat de l'Université Paul Sabatier, Toulouse, 2000.
98. L. Kremer, S.S. Gurcha, P. Bifani, P.G. Hitchen, A. Baulard, H.R. Morris, A. Dell, P.J. Brennan, G.S. Besra, Characterization of a putative alpha-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis, Biochem. J. 363 (2002) 437-447.
99. J. Kordulakova, M. Gilleron, K. Mikusova, G. Puzo, P.J. Brennan, B. Gicquel. M. Jackson, Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis. PimA is essential for growth of mycobacteria, J. Biol. Chem. 277 (2002) 31335-31344.
100. M.L. Schaeffer, K.H. Khoo, G.S. Besra, D. Chatterjee, P.J. Brennan, J.T. Belisle, J.M. Inamine, The pimB gene of Mycobacterium tuberculosis encodes a mannosyltransferase involved in lipoarabinomannan biosynthesis, J. Biol. Chem. 274 (1999) 31625-31631.
101. P. Brennan, C.E. Ballou, Biosynthesis of mannophosphoinositides by Mycobacterium phlei. Enzymatic acylation of the dimannophosphoinositides, J. Biol. Chem. 243 (1968) 2975-2984.
102. K. Takayama, D.S. Goldman, Pathway for the synthesis of mannophospholipids in Mycobacterium tuberculosis, Biochim. Biophys. Acta 176 (1969) 196-198.
103. P. Nalini, G.K. Khuller, Biosynthesis of hexamannophosphoinositides in Mycobacterium smegmatis ATCC 607, Arch. Microbiol. 132 (1982) 87-90.
104. S. Mayor, A.K. Menon, G.A. Cross, Glycolipid precursors for the membrane anchor of Trypanosoma brucei variant surface glycoproteins. II. Lipid structures of phosphatidylinositol-specific phospholipase C sensitive and resistant glycolipids, J. Biol. Chem. 265 (1990) 6174-6181.
105. M.A. Ferguson, Site of palmitoylation of a phospholipase C-resistant glycosylphosphatidylinositol membrane anchor, Biochem. J. 284 (1992) 297-300.
106. G.S. Besra, C.B. Morehouse, C.M. Rittner, C.J. Waechter, P.J. Brennan, Biosynthesis of mycobacterial lipoarabinomannan, J. Biol. Chem. 272 (1997) 18460-18466.
107. S.S. Gurcha, A.R. Baulard, L. Kremer, C. Locht, D.B. Moody, W. Muhlecker, C.E. Costello, D.C. Crick, P.J. Brennan, G.S. Besra, Ppm1, a novel polyprenol monophosphomannose synthase from Mycobacterium tuberculosis, Biochem. J. 365 (2002) 441-450.
108. B.A. Wolucka, M.R. McNeil, E. De Hoffmann, T. Chojnacki, P.J. Brennan, Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria, J. Biol. Chem. 269 (1994) 23328-23335.
109. K. Mikusova, R.A. Slayden, G.S. Besra, P.J. Brennan, Biogenesis of the mycobacterial cell wall and the site of action of ethambutol, Antimicrob. Agents Chemother. 39 (1995) 2484-2489.
110. V.E. Escuyer, M.A. Lety, J.B. Torrelles, K.H. Khoo, J.B. Tang, C.D. Rithner, C. Frehel, M.R. McNeil, P.J. Brennan, D. Chatterjee, The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan, J. Biol. Chem. 276 (2001) 48854-48862.
111. D. Kaur, T.L. Lowary, V.D. Vissa, D.C. Crick, P.J. Brennan, Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans, Microbiology 148 (2002) 3049-3057.